Are biogenic amines involved in controlling upper airway patency during REM sleep?

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 10, 2005, Pages 1237-1238

  Greer, John J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOGENIC AMINE; CARBACHOL; METHYSERGIDE; MIANSERIN; PRAZOSIN; SEROTONIN ANTAGONIST;

ADRENERGIC SYSTEM; DAYTIME SOMNOLENCE; DRUG EFFICACY; EDITORIAL; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; MOTONEURON; NONHUMAN; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REM SLEEP; SEROTONINERGIC SYSTEM; SLEEP APNEA SYNDROME; SLEEP WAKING CYCLE; UPPER RESPIRATORY TRACT;

HUMANS; RESPIRATION; SEROTONIN; SLEEP, REM;

EID: 30444448736     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.2508007     Document Type: Editorial

References (16)

1. Ferini-Strambi L, Fantini ML, Castronovo C. Epidemiology of obstructive sleep apnea syndrome. Minerva Med 2004;95:187-202.
2. Gastaut H, Tassinari CA, Duron B. Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Res 1966;1:167-186.
3. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978;44:931-938.
4. Smith IE, Quinnell TG. Pharmacotherapies for obstructive sleep apnoea: where are we now? Drugs 2004;64:1385-1399.
5. Fenik VB, Davies RO, Kubin L. REM sleep-like atonia of hypoglossal (XII) motoneurons is caused by loss of noradrenergic and serotonergic inputs. Am J Respir Crit Care Med 2005;172:1322-1330.
6. Kubin L. Carbachol models of REM sleep: recent developments and new directions. Arch Ital Biol 2001;139:147-168.
7. Funk GD, Smith JC, Feldman JL. Development of thyrotropin-releasing hormone and norepinephrine potentiation of inspiratory-related hypoglossal motoneuron discharge in neonatal and juvenile mice in vitro. J Neurophysiol 1994;72:2538-2541.
8. Al-Zubaidy ZA, Erickson RL, Greer JJ. Serotonergic and noradrenergic effects on respiratory neural discharge in the medullary slice preparation of neonatal rats. Pflugers Arch 1996;431:942-949.
9. Bayliss DA, Viana F, Talley EM, Berger AJ. Neuromodulation of hypoglossal motoneurons: cellular and developmental mechanisms. Respir Physiol 1997;110:139-150.
10. Fenik P, Veasey SC. Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus. Am J Respir Crit Care Med 2003;167:563-569.
11. Kubin L, Tojima H, Reignier C, Pack AI, Davies RO. Interaction of serotonergic excitatory drive to hypoglossal motoneurons with carbachol-induced, REM sleep-like atonia. Sleep 1996;19:187-195.
12. Jelev A, Sood S, Liu H, Nolan P, Horner RL. Microdialysis perfusion of 5-HT into hypoglossalmotor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats. J Physiol 2001;532:467-481.
13. Feldman JL,Neverova NV, Saywell SA. Modulation of hypoglossal motoneuron excitability by intracellular signal transduction cascades. Respir Physiol Neurobiol 2005;147:131-143.
14. Sood S, Morrison JL, Liu H, Horner RL. Role of endogenous serotonin in modulating genioglossus muscle activity in awake and sleeping rats. Am J Respir Crit Care Med 2005;172:1338-1347.
15. Fuller DD, Baker TL, Behan M, Mitchell GS. Expression of hypoglossal long-term facilitation differs between substrains of Sprague-Dawley rat. Physiol Genomics 2001;4:175-181.
16. Feldman JL, Janczewski WA. Slip of the tongue. Am J Respir Crit Care Med 2004;170:581-582.